Beacon Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	377.47	227.87	306.95	452.19	538.5	337.84
Short-Term Investments	34.8	16.24	15.36	26.33	6.16	5.87
Cash & Short-Term Investments	412.27	244.1	322.32	478.52	544.66	343.71
Cash Growth	-	-24.27%	-32.64%	-12.14%	58.46%	-43.97%
Accounts Receivable	2,927	2,488	2,758	2,081	1,964	1,933
Other Receivables	763.92	545.44	224.79	134.55	-	-
Receivables	6,173	5,152	5,610	4,947	2,486	2,337
Inventory	4,237	3,323	2,888	1,992	1,972	1,279
Other Current Assets	3,504	4,149	3,897	1,566	1,301	1,016
Total Current Assets	14,327	12,868	12,717	8,983	6,444	5,216
Property, Plant & Equipment	6,555	6,519	6,187	5,648	4,371	3,319
Long-Term Investments	-	-	-	-	1.03	0.87
Other Intangible Assets	10.3	16.53	27.98	10.79	-	-
Other Long-Term Assets	-	-	-	-	-	0
Total Assets	20,892	19,404	18,932	14,642	10,816	8,536
Accounts Payable	856.82	610.95	905.7	297.45	32.51	113.67
Accrued Expenses	-	317.58	310.19	209.52	448.83	354.26
Short-Term Debt	5,711	5,973	6,699	6,500	3,413	1,884
Current Portion of Long-Term Debt	603.66	911.12	891.43	182.55	216.01	225.9
Current Portion of Leases	42.48	19.42	-	-	-	-
Current Income Taxes Payable	597.2	383.15	246.13	79.54	258.59	-18.65
Other Current Liabilities	1,074	130.94	209.71	220.88	305.13	233.92
Total Current Liabilities	8,885	8,346	9,262	7,490	4,674	2,793
Long-Term Debt	2,997	3,193	2,729	772.48	197.91	387.75
Long-Term Leases	97.98	110.59	-	-	-	-
Pension & Post-Retirement Benefits	1,018	917.28	673.74	323.95	-	-
Long-Term Deferred Tax Liabilities	144.03	169.37	176.57	113.44	-	-
Total Liabilities	13,142	12,737	12,841	8,700	4,872	3,180
Common Stock	2,310	2,310	2,310	2,310	2,310	2,310
Retained Earnings	4,853	3,640	2,892	2,565	2,404	1,639
Comprehensive Income & Other	586.96	716.94	888.6	1,067	1,229	1,406
Shareholders' Equity	7,750	6,667	6,090	5,942	5,944	5,355
Total Liabilities & Equity	20,892	19,404	18,932	14,642	10,816	8,536
Total Debt	9,452	10,207	10,319	7,455	3,827	2,497
Net Cash (Debt)	-9,040	-9,963	-9,997	-6,977	-3,282	-2,153
Net Cash Per Share	-39.13	-43.13	-43.28	-30.20	-14.21	-9.32
Filing Date Shares Outstanding	231	231	231	231	231	231
Total Common Shares Outstanding	231	231	231	231	231	231
Working Capital	5,442	4,522	3,455	1,493	1,770	2,423
Book Value Per Share	33.55	28.86	26.37	25.72	25.73	23.18
Tangible Book Value	7,739	6,651	6,062	5,931	5,944	5,355
Tangible Book Value Per Share	33.50	28.79	26.24	25.68	25.73	23.18
Land	687.22	663.81	663.81	657.98	624.1	566.06
Buildings	2,649	2,649	2,208	1,083	978.41	978.41
Machinery	5,400	5,143	4,745	4,014	3,031	2,465
Construction In Progress	1,231	1,094	1,130	1,957	1,299	437.22